Current and emerging therapies to prevent hereditary angioedema attacks.
Current and emerging therapies to prevent hereditary angioedema attacks.
Am J Manag Care. 2018 Aug;24(14 Suppl):S299-S307
Authors: Lumry WR
Abstract
Hereditary angioedema (HAE) is a rare genetic disease defined by recurrent attacks of edema, causing a substantial burden for patients, with morbidity, mortality, and reduced quality of life. This burden is increased by delayed diagnosis, inappropriate treatment, and suboptimal follow-up and patient education. Several novel therapeutics have recently been approved or are currently under evaluation for prevention of HAE attacks.
PMID: 30132644 [PubMed - in process]
Source: The American Journal of Managed Care - Category: Health Management Authors: Lumry WR Tags: Am J Manag Care Source Type: research
More News: Education | Genetics | Health Management | Managed Care | Universities & Medical Training